Tristel (TSTL) Competitors GBX 347 -5.50 (-1.56%) As of 02/21/2025 12:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider Trades TSTL vs. AMS, BVC, SPEC, AKR, CNSL, ODX, CTEC, UPR, CSRT, and SLNShould you be buying Tristel stock or one of its competitors? The main competitors of Tristel include Advanced Medical Solutions Group (AMS), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Uniphar (UPR), Consort Medical plc (CSRT.L) (CSRT), and Silence Therapeutics (SLN). These companies are all part of the "medical" sector. Tristel vs. Advanced Medical Solutions Group BATM Advanced Communications INSPECS Group Akers Biosciences Cambridge Nutritional Sciences Omega Diagnostics Group ConvaTec Group Uniphar Consort Medical plc (CSRT.L) Silence Therapeutics Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, community ranking, risk, valuation, earnings and dividends. Which has more volatility & risk, AMS or TSTL? Advanced Medical Solutions Group has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Does the media prefer AMS or TSTL? In the previous week, Tristel had 3 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 3 mentions for Tristel and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.18 beat Tristel's score of -0.34 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media. Company Overall Sentiment Advanced Medical Solutions Group Positive Tristel Neutral Is AMS or TSTL more profitable? Tristel has a net margin of 15.47% compared to Advanced Medical Solutions Group's net margin of 8.49%. Tristel's return on equity of 20.43% beat Advanced Medical Solutions Group's return on equity.Company Net Margins Return on Equity Return on Assets Advanced Medical Solutions Group8.49% 4.57% 2.35% Tristel 15.47%20.43%9.89% Do insiders & institutionals believe in AMS or TSTL? 58.2% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 50.4% of Tristel shares are owned by institutional investors. 3.1% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 4.9% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable earnings and valuation, AMS or TSTL? Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdvanced Medical Solutions Group£132.18M3.46£11.22M£5.1641.08Tristel£42.24M3.92£6.54M£13.6625.40 Is AMS or TSTL a better dividend stock? Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 0.9%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.7%. Advanced Medical Solutions Group pays out 38.8% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do analysts prefer AMS or TSTL? Advanced Medical Solutions Group presently has a consensus target price of GBX 300, suggesting a potential upside of 41.51%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Medical Solutions Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tristel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in AMS or TSTL? Advanced Medical Solutions Group received 18 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 50.00% of users gave Advanced Medical Solutions Group an outperform vote. CompanyUnderperformOutperformAdvanced Medical Solutions GroupOutperform Votes16650.00% Underperform Votes16650.00% TristelOutperform Votes14857.36% Underperform Votes11042.64% SummaryAdvanced Medical Solutions Group beats Tristel on 11 of the 20 factors compared between the two stocks. Get Tristel News Delivered to You Automatically Sign up to receive the latest news and ratings for TSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSTL vs. The Competition Export to ExcelMetricTristelMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£165.76M£3.78B£5.84B£2.63BDividend Yield3.86%1.99%4.76%4.98%P/E Ratio25.4019.9318.26163.09Price / Sales3.92405.46434.47312,084.14Price / Cash20.96146.5438.4228.02Price / Book5.082.717.645.14Net Income£6.54M£99.80M£3.18B£5.73B7 Day Performance-4.53%-1.65%-1.95%-0.99%1 Month Performance-12.26%0.82%-0.23%-0.81%1 Year Performance-22.89%-5.49%16.69%39.25% Tristel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSTLTristelN/AGBX 347-1.6%N/A-22.4%£165.76M£42.24M25.40208AMSAdvanced Medical Solutions Group2.371 of 5 starsGBX 219-0.5%GBX 300+37.0%+1.2%£472.88M£132.18M42.4410Positive NewsBVCBATM Advanced CommunicationsN/AGBX 17.61-4.1%N/A-14.3%£93.49M£130.32M-408.73980News CoverageGap DownSPECINSPECS GroupN/AGBX 50.06-3.7%N/A-22.0%£50.90M£195.14M-12.391,673AKRAkers BiosciencesN/AN/AN/AN/A£21.64M£2.32M-0.44120CNSLCambridge Nutritional SciencesN/AGBX 3.25-7.1%N/A+19.7%£7.73M£9.77M-362.103,200Gap DownODXOmega Diagnostics GroupN/AN/AN/AN/A£5.23M£7.55M-220.0091Gap DownCTECConvaTec Group1.7317 of 5 starsGBX 243.740.0%GBX 301.67+23.8%+0.4%£6.20B£2.71B41.0510,000News CoverageUPRUniphar2.2374 of 5 starsGBX 198.04-1.0%GBX 310+56.5%-19.3%£616.46M£3.03B13.773,000CSRTConsort Medical plc (CSRT.L)N/AN/AN/AN/A£504.60M£298.60M127.85N/ASLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume Related Companies and Tools Related Companies Advanced Medical Solutions Group Competitors BATM Advanced Communications Competitors INSPECS Group Competitors Akers Biosciences Competitors Cambridge Nutritional Sciences Competitors Omega Diagnostics Group Competitors ConvaTec Group Competitors Uniphar Competitors Consort Medical plc (CSRT.L) Competitors Silence Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:TSTL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tristel plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tristel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
